Sam Altman-backed Retro Biosciences is widening its Alzheimer’s trial after early doses showed no red flags. Most drug trials ...
APLMS will use Singapore, China and India to test how longevity science can translate into function, prevention and healthier ...
Outer Bio’s Yuna platform keeps living human skin functioning for a month, a longer window for testing what actually slows ...
A SIRT6 gene therapy trial in senior beagles hit its primary endpoint, lowering biological age and offering a test bed for human medicine.
New MOU pairs GlycanAge’s glycan-based biological age test with ExoEarth’s exosome platform, bringing inflammaging testing ...
Prevention gets tech budget it deserves as a $499, hour-long body scan backed by Zuckerberg and Sharapova lands in SoHo.
A 350-patient study finds a palm-sized ECG device spots dangerous heart rhythms that hospital-grade monitors miss entirely.
Aesthetics empire opens its first wellness clinic, and it says something about where precision longevity in Southeast Asia is ...
New $1.08m grant aimed at the immune biology behind stem cell transplants, a research problem getting more urgent as more ...
Obesity biotech aims to reduce fat while preserving lean mass, with first-in-human studies planned for late 2027.
Facing a legal challenge to its sleep-tracking claims, Oura is publishing the science behind its ring, with real stakes for ...
Leisure exercise lowers dementia risk, while physically demanding jobs may raise it – twist that reshapes how we think about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results